Customer Service:
Mon - Fri: 8:30 am - 6 pm EST

 Historical

ISO/TS 20399-1:2018

Biotechnology - Ancillary materials present during the production of cellular therapeutic products - Part 1: General requirements

This document specifies definitions and general requirements for ancillary materials (AMs) used in cell processing of cellular therapeutic products.

This document is applicable to cellular therapeutic products, including those gene therapy products whereby cells form part of the final product. It does not apply to products without cells.

This document does not cover the selection, assessment or control of starting materials and excipients.

NOTE International, regional or national regulations or requirements can also apply to specific topics covered in this document.


Content Provider
International Organization for Standardization [iso]


Others Also Bought

Biotechnology - Ancillary materials present during the production of cellular therapeutic products - Part 2: Best ...
Biotechnology - Ancillary materials present during the production of cellular therapeutic products - Part 3: Best ...
Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
Document History
Revised By:
Included in Packages
This standard is not included in any packages.
Amendments & Corrections
We have no amendments or corrections for this standard.
ANSI Logo

As the voice of the U.S. standards and conformity assessment system, the American National Standards Institute (ANSI) empowers its members and constituents to strengthen the U.S. marketplace position in the global economy while helping to assure the safety and health of consumers and the protection of the environment.

CUSTOMER SERVICE
NEW YORK OFFICE
ANSI HEADQUARTERS